Article
Synergistic targeting of cancer cells through simultaneous inhibition of key metabolic enzymes
2025-05-08
Abstract excerpt
As cancer cell specific rewiring of metabolic networks creates potential therapeutic opportunities, we conducted a synthetic lethal screen utilizing inhibitors of metabolic pathways. Simultaneous administration of (R)-GNE-140 and BMS-986205 (Linrodostat) preferentially halted proliferation of ovarian cancer cells, but not of their non-oncogenically transformed progenitor cells. While (R)-GNE-140 inhibits lactate d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ca092983-2bbf-5172-a87c-4cab7ada9a57
- DOI
- 10.1101/2025.05.02.651820
